scholarly journals Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Placebo‐Controlled REGAIN, and Pooled EVOLVE‐1 and EVOLVE‐2 Studies

2020 ◽  
Vol 60 (10) ◽  
pp. 2202-2219
Author(s):  
Todd A. Smitherman ◽  
Gretchen E. Tietjen ◽  
Kory Schuh ◽  
Vladimir Skljarevski ◽  
Sarah Lipsius ◽  
...  
Keyword(s):  
Medical History ◽  
Migraine Prevention ◽  
Phase 3 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Post Hoc Analysis ◽  
History Of ◽  
Post Hoc

scholarly journals Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster Headache

2021 ◽  
Vol Volume 14 ◽  
pp. 2059-2070
Author(s):  
J Scott Andrews ◽  
David Kudrow ◽  
Mallikarjuna Rettiganti ◽  
Tina Oakes ◽  
Jennifer N Bardos ◽  
...  
Keyword(s):  
Cluster Headache ◽  
Controlled Study ◽  
Phase 3 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Post Hoc Analysis ◽  
Total Pain ◽  
Episodic Cluster Headache ◽  
Post Hoc
Sign in / Sign up

Export Citation Format

Share Document